Matthew R. Gardner
- Molecular Biology
- Virology top 2%
- Genetics
- Immunology
- Infectious Diseases top 10%
- Co-authors
- Michael FarzanKelli HooverDavid HughesJames M. SlavicekJames McNeilMichael GroveBarnett AlfantMeredith E. Davis-Gardner
- Topics
- HIV Research and Treatment (22 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)Virus-based gene therapy research (9 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Matthew R. Gardner
38 papers receiving 767 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 306
- Virology 260
- Genetics 175
- Immunology 158
- Infectious Diseases 143
Countries citing papers authored by Matthew R. Gardner
This map shows the geographic impact of Matthew R. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Gardner more than expected).
Fields of papers citing papers by Matthew R. Gardner
This network shows the impact of papers produced by Matthew R. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Gardner. The network helps show where Matthew R. Gardner may publish in the future.
Co-authorship network of co-authors of Matthew R. Gardner
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Gardner. A scholar is included among the top collaborators of Matthew R. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Gardner. Matthew R. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 20 | |
| 8 | 34 | |
| 9 | 26 | |
| 10 | 44 | |
| 11 | 35 | |
| 12 | 11 | |
| 13 | 1 | |
| 14 | 23 | |
| 15 | 17 | |
| 16 | 21 | |
| 17 | 14 | |
| 18 | 93 | |
| 19 | 8 | |
| 20 | 24 |
About Matthew R. Gardner
Matthew R. Gardner is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 38 papers that have together received 785 indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Virology (260 citations), Insect Science (122 citations) and Infectious Diseases (143 citations). Matthew R. Gardner has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Michael Farzan, Kelli Hoover, David Hughes, James M. Slavicek, James McNeil, Michael Grove, Barnett Alfant, Meredith E. Davis-Gardner, Brian D. Quinlan and Stephen Dorling. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.